The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 08, 2018

Filed:

Feb. 22, 2013
Applicants:

Oragenics, Inc., Alachua, FL (US);

The Texas A&m University System, College Station, TX (US);

Inventors:

Jeffrey D. Hillman, Gainesville, FL (US);

James Leif Smith, College Station, TX (US);

Shawanda R. Wilson-Stanford, College Station, TX (US);

Assignees:

Oragenics, Inc., Alachua, FL (US);

The Texas A&M University System, College Station, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/195 (2006.01); A61K 39/09 (2006.01); C07K 14/315 (2006.01); A23G 4/12 (2006.01); A23L 2/52 (2006.01); A61K 8/99 (2017.01); A61K 35/744 (2015.01); A61Q 11/00 (2006.01); C12N 9/04 (2006.01); A01N 25/34 (2006.01); A01N 63/02 (2006.01); A61K 38/16 (2006.01); A61K 45/06 (2006.01); A61K 8/64 (2006.01); A61K 39/02 (2006.01); A61K 38/12 (2006.01);
U.S. Cl.
CPC ...
C07K 14/195 (2013.01); A01N 25/34 (2013.01); A01N 63/02 (2013.01); A23G 4/123 (2013.01); A23L 2/52 (2013.01); A61K 8/64 (2013.01); A61K 8/99 (2013.01); A61K 35/744 (2013.01); A61K 38/164 (2013.01); A61K 39/09 (2013.01); A61K 45/06 (2013.01); A61Q 11/00 (2013.01); C07K 14/315 (2013.01); C12N 9/0006 (2013.01); A23V 2002/00 (2013.01); A61K 38/12 (2013.01); A61K 39/02 (2013.01); A61K 2800/74 (2013.01); C12Y 101/01001 (2013.01);
Abstract

The invention provides improvements of lantibiotics useful for reducing the numbers of microbes or the reproduction of microbes in or on subjects or objects. One embodiment of the invention provides variants of antibiotics wherein the amino acid at position (1) is changed to Ile or Gly, the amino acid at position (4) is changed to an Ala, the amino acid at position (4) is removed, the amino acid at position (5) is changed to an Ala, or wherein, as in the case of MU1140, the amino acid at position (13) is Arg, the Arg at position (13) is substituted with Asp, or combinations of two or more these changes or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…